HKSTP and AstraZeneca signing MOU on Strategic Collaboration
Hong Kong Science and Technology Parks (HKSTP) continues to strengthen the strategic partnership with AstraZeneca, one of the world's leading pharmaceutical companies. The goal of this collaboration is to position Hong Kong and the Greater Bay Area as a trailblazer in life science innovation and serve as a model for the region. This marks a milestone that HKSTP has entered into a multidimensional collaboration, which includes technology and data sharing, with a life science corporation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230404005674/en/
Mr Albert Wong, CEO of Hong Kong Science and Technology Parks (left, front row) and Ms Shan Wu, General Manager, AstraZeneca Hong Kong and Macau (right, front row) signed the Co-incubation Programme. Witnessed by Dr Sunny Chai, BBS, JP, Chairman, Hong Kong Science and Technology Parks Corporation (2nd from left, 2nd row), Ms Lillian Cheong, JP, Under Secretary, Innovation, Technology and Industry Bureau (middle, 2nd row), Sir Pascal Soriot, Chief Executive of AstraZeneca (2nd from right, 2nd row), Mr Leon Wang, Executive Vice President, International and China President, AstraZeneca (right, 2nd row) and Dr Grace Lau, Head of Institute for Translational Research Hong Kong Science and Technology Parks Corporation (left, 2nd row).
Since 2021, AstraZeneca and HKSTP have been collaborating, and this partnership will not only continue but also be upgraded. The extended collaboration involves AstraZeneca and HKSTP supporting and providing services to startup companies under the HKSTP co-incubation programme. Additionally, the collaboration includes attracting more overseas and China mainland companies to the HKSTP community, with the aim of connecting them with hospitals, key opinion leaders in the Greater Bay Area, and universities in Hong Kong.
The 2022 Policy Address emphasised the city's commitment to fostering innovation and technology. AstraZeneca and HKSTP share the same aspiration to partner with the HKSAR government to improve the healthcare ecosystem in Hong Kong.
AstraZeneca will also provide consultation on setting up international offices in Hong Kong and support connecting overseas investors with HKSTP co-incubation programs. Besides, roadshow sessions at HKSTP will be held for overseas and China R&D Health Conferences to forge non-traditional partnerships across geographical boundaries, facilitating collaborative action and opening up new opportunities to enhance patient-enabled innovation.
The MOU was signed by Ms Shan Wu, General Manager of AstraZeneca Hong Kong and Macau, and Mr Albert Wong, Chief Executive Officer of HKSTP, at a ceremony witnessed by Sir Pascal Soriot, Chief Executive Officer of AstraZeneca, Mr Leon Wang, Executive Vice President, International and China President of AstraZeneca, and Dr Sunny Chai, Chairman of HKSTP.
Dr Sunny Chai, Chairman of HKSTP, expressed his delight in witnessing the collaboration between HKSTP and AstraZeneca in building a healthcare innovation ecosystem in Hong Kong. “Biotechnology is important not only to Hong Kong’s economic development but also humankind. Aligning with the Hong Kong Innovation and Technology Development Blueprint, HKSTP is fully committed to pioneering its success by welcoming talent, companies and investment globally to benefit from Hong Kong’s established track record in R&D, advanced manufacturing as well as commercialisation. This latest agreement is another major milestone in our partnership with AstraZeneca and further builds upon the positive momentum within HKSTP’s biotechnology ecosystem.”
Ms Lillian Cheong, Under Secretary for Innovation, Technology and Industry, said: “Promoting the development of I&T is of top priorities of the SAR Government. The National 14th Five-Year Plan also provides staunch support for Hong Kong's development as an international I&T hub. The SAR Government proposed to focus on industries with an edge including life and health technology, and formulate attractive special facilitation measures to attract prominent companies to set foot in Hong Kong or expand their existing businesses here. I am pleased to see the collaboration between AZHK and HKSTP which is not only a testament to Hong Kong’s great R&D capabilities in life and health technology, but also demonstrates the co-operation between the upstream and downstream sectors. I look forward to joining hands with all of you to fully seize the golden development opportunities ahead.”
Mr Leon Wang, Executive Vice President, International and China President of AstraZeneca, expressed his enthusiasm for the partnership between HKSTP and AstraZeneca. “As a global pharmaceutical leader with strong connections to business leaders, scientists, marketers, and investors around the world, AstraZeneca is well-equipped to help nurture more health talents and drive significant growth in Hong Kong's medical research, drug development, and clinical trial processes.”
Dr Grace Lau, Head of Institute for Translational Research, HKSTP, emphasised the importance of attracting more large multinationals to become co-incubators and establish research and development laboratories within the HKSTP ecosystem. Multinationals provide invaluable mentorship, sharing their resources and expertise with startups. HKSTP has already established partnerships with multinationals that operate innovation centres overseas, effectively extending their incubation program to other parts of the world. Additionally, they hope to draw more quality startups to Hong Kong with the help of these multinational partners.
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) has for over 20 years committed to building up Hong Kong as an international innovation and technology hub to propel success for local and global pioneers today and tomorrow. HKSTP has established a thriving I&T ecosystem that is home to two unicorns and Hong Kong’s leading R&D hub with over 12,000 research professionals and over 1,200 technology companies focused on healthtech, AI and robotics, fintech and smart city technologies.
Established in 2001, we attract and nurture talent, accelerate and commercialise innovation and technology for entrepreneurs on their journey of growth in Hong Kong, to the Greater Bay Area, Asia and beyond. Our growing innovation ecosystem is built around our key locations of Hong Kong Science Park in Shatin, InnoCentre in Kowloon Tong and three modern INNOPARKs in Tai Po, Tseung Kwan O and Yuen Long. The three INNOPARKs are realising a vision of new industrialisation for Hong Kong. The goal is sectors like advanced manufacturing, electronics and biotechnology are being reimagined for a new generation of industry.
Through our infrastructure, services, expertise and network of partnerships, HKSTP will help establish innovation and technology as a pillar of growth for Hong Kong, while reinforcing Hong Kong’s international I&T hub status as a launchpad for global growth at the heart of the GBA innovation powerhouse.
More information about HKSTP is available at www.hkstp.org.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com.hk.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230404005674/en/
Contact information
Media:
PRPPL Consultancy Limited
Lee Sze Wing
Tel: +852 9811 3380
Email: w.lee@prppl.com
Edelman Public Relations
Sonia Leung
Tel: +852 2837 4775
Email: Sonia.Leung@edelman.com/ Edelmanhkstppr@edelman.com
Hong Kong Science & Technology Parks Corporation
Julia Cheung
Tel: +852 2629 6891
Email: julia.cheung@hkstp.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirion to Join the U.S. Industry Program at the 69th IAEA General Conference in Vienna, Austria11.9.2025 23:39:00 EEST | Press release
Mirion, a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, is honored to announce its invitation to attend the 69th International Atomic Energy Agency (IAEA) General Conference. Scheduled for September 15–19 in Vienna, Austria, this annual event brings together key stakeholders from across the globe to discuss issues critical to nuclear safety, security, and peaceful applications of nuclear technology. Representing Mirion at the General Conference will be Chairman and Chief Executive Officer Thomas Logan and Chief Financial Officer Brian Schopfer. Their presence underscores the distinguished role Mirion plays as an industry leader in nuclear measurement, radiation protection, and safety solutions, in addition to its commitment to innovation and advancing global energy solutions. “We are honored to participate in this important global gathering,” Logan said. “The IAEA plays a crucial role
René Lammers Appointed Chief Research & Innovation Officer of The Estée Lauder Companies11.9.2025 23:25:00 EEST | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of René Lammers, Ph.D. as Executive Vice President, Chief Research & Innovation Officer, effective October 1, 2025. Mr. Lammers will report directly to Stéphane de La Faverie, President and Chief Executive Officer, and will join the company’s Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911004836/en/ René Lammers, Ph.D., Executive Vice President, Chief Research & Innovation Officer “René is an exceptional and innovative leader whose deep scientific expertise, global perspective, and passion for cutting-edge product development will be instrumental as we transform our approach to research and innovation to more fully align with our focus on consumer centricity,” said Mr. de La Faverie. “Creating transformative innovation is integral to our strategic vision of Beauty Reimagined, and with René’s leadership, we are elevating our capab
RTL Luxembourg Expands Deployment of Verimatrix Technologies to Protect Premier Auto Racing Against Piracy11.9.2025 18:45:00 EEST | Press release
Regulatory News: Verimatrix, (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that RTL Luxembourg, the country’s leading media company, has further expanded its use of Verimatrix anti-piracy tools to now include the full Streamkeeper suite of solutions. Initially deploying Streamkeeper Multi-DRM, RTL Luxembourg also recently implemented Counterspy, Deepscan and Watermarking solutions – the industry’s latest set of powerful tools that help further bolster proactive protections for RTL’s motorsport content revenue. It was announced in April 2024 that RTL Luxembourg selected Verimatrix Streamkeeper Multi-DRM to ensure that RTL Luxembourg remained in full control of its valuable digital assets while also consistently keeping costs low and preventing unneeded technical complexities. With the addition of Verimatrix’s Counterspy, RTL Luxembourg further expands its ability to detect unauthorized content distribution in real-time, depl
Xylem and Amazon Partner on Smart Water Upgrades to Save More Than 1.3 Billion Liters Annually in Mexico11.9.2025 17:00:00 EEST | Press release
Residents in Mexico City and Monterrey will soon enjoy more reliable water supply as the two cities launch groundbreaking infrastructure upgrades to save over 1.3 billion liters of water a year – easing pressure from the rapid urbanization and persistent drought conditions that have strained local water systems. The two cities are working in partnership with global water technology company Xylem (NYSE: XYL) and Amazon (NASDAQ: AMZN) to deploy Xylem Vue, an advanced software platform that applies data and analytics to detect leaks, cut water losses and improve residents’ water supply. The projects are estimated to save upwards of 800 million liters of water a year in Mexico City and 560 million liters a year in Monterrey. “In a water-stressed region, where every liter counts, recovering more than a billion liters of water each year is a game-changer,” said Jaime Barba, General Manager, Xylem Vue. “Working with Amazon and the local water utilities, we are using data to give these cities
HTEC Partners with World Economic Forum11.9.2025 16:56:00 EEST | Press release
HTEC, a global digital engineering and product development company, has today announced that it has joined the World Economic Forum’s (WEF) Centre for AI Excellence. HTEC will contribute to the community through its expertise and thought leadership to help advance AI adoption and AI innovation across its core industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911910448/en/ HTEC Partners with World Economic Forum to bring AI expertise to help with industry transformation and real-world outcomes WEF’s Centre for AI Excellence is bringing together leading industry organisations and experts to work together to advance the pace and positive impact AI can have in economies and societies. Its goal is to unlock transformative potential in an equitable and human-centered way, which is well aligned with HTEC’s principles and values. As an AI-first organization, HTEC blends deep engineering expertise with strategic insight.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom